Carolina Barros

📍Portugal
🩺 MD, MSc, Internal Medicine
🧠 Stroke Center

[Amit Chaudhari MD @NeuroIRdoc]

https://t.co/rY4Nk30579

[European Stroke Org @ESOstroke]

Presented at #ESOC2026: The updated guideline on blood pressure management in acute stroke provides recommendations for patients with acute ischaemic stroke and intracerebral haemorrhage.

🔗 Read: https://t.co/6GF7ia6qHm

▶️ Watch: https://t.co/JDrUL728lW

#ESOGuidelines

[International Journal of Stroke @IntJStroke]

💊Early DOAC initiation is safe and non-inferior to delayed treatment regardless of infarct volume

❌⏱️No evidence that anticoagulation initiation should be delayed beyond 4 days on the basis of infarct size

Read the paper here!👇
https://t.co/3P82y5V7hu @UCLStrokeRes

[International Journal of Stroke @IntJStroke]

💊Early DOAC initiation is safe and non-inferior to delayed treatment regardless of infarct volume

❌⏱️No evidence that anticoagulation initiation should be delayed beyond 4 days on the basis of infarct size

Read the paper here!👇
https://t.co/3P82y5V7hu @UCLStrokeRes

[SPAVC @SPAVC_pt]

🆕A Madeira recebeu recentemente a distinção de “Região Angels”, atribuída pela Angels Portugal, que reconhece a região como segura no atendimento a doentes com AVC.

#SPAVC #RegiãoAngels https://t.co/FYh7JS6YH4

[Stroke AHA/ASA @StrokeAHA_ASA]

SWITCHing the Light On: Decompressive Craniectomy in Deep ICH — Does Location Matter?

In this #BloggingStroke post, @NaeiriP discusses #Stroke article by Polymeris et al. @vajkoczy @DavidSeiffge @bmsiepen @FishingNeurons

https://t.co/aCVimqgDIh

[International Journal of Stroke @IntJStroke]

🇨🇳📰Chinese guidelines for diagnosis and treatment of intracranial atherosclerotic stenosis

Primary Strategies for ICAS:
📌Symptomatic: intensive medical management
📌Asymptomatic: control of vascular risk factors

Read more here👇
https://t.co/9kVXK1Kqwi

[Dr. Negar Asdaghi @NAsdaghi]

Time to move on from Rope score to Pascal ( Rope + LS, ASA). Remember that PFO closure confers benefit by reducing recurrent stroke but also potential harm by increasing atrial fibrillation. Closure in Unlikely pascal group causes harm. @StrokeAHA_ASA

[AHA Science @AHAScience]

The 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke aims to cover the full course of the emergency evaluation and early management of the patient with AIS. This includes the earliest interaction with the health care system in the prehospital space, early evaluation and treatment, and in-hospital management of patients with AIS.

📷 Journey of a patient with AIS.

✍🏼 @annealexandrov @AlexandraCzap @OanaDumitrascu5Koto @ashupjadhav @BarrowNeuro @SVINjournal @PoojaKhatriMD @wtkimberly @brianmacgrory @tmadsenem @eva_mistry @natperezossa @strokemaven @PSporns @stavtjoumakaris @WFNeurosurgery @shadiyaghi2

[Stroke AHA/ASA @StrokeAHA_ASA]

Is Exclusion of Patients on Oral Anticoagulants From IV Thrombolysis Really Necessary?

In this #BloggingStroke post, @JohannaSeidenMD discusses #Stroke article by @TotoMynell et al. https://t.co/bhjCFgVior

[World Stroke Academy @WorldStrokeEd]

#MondayTip

🤔What to do with a “true breakthrough stroke”?
After a systematic evaluation 👉https://t.co/lCYj4BCIOE, many AF strokes on DOAC will be true breakthroughs -i.e., despite correct indication, dose, adherence

🔬Emerging strategies under study 👇
Would you add another?

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE: Population-based data show that convexity subarachnoid hemorrhage (cSAH) due to cerebral amyloid angiopathy (CAA) is rare (1.6/100,000 person-years ≥50 yrs) but carries a high 3-year risk of intracerebral hemorrhage (31%). https://t.co/XnydglBlC0

[Cardiotipss @cardiotipss]

‼️ Momento de iniciar la anticoagulación en pacientes con EVC isquemico y FA
📚 Artículos a leer: ELAN,ÓPTIMAS,CATALYST,TIMING,START
✅ Inicio de anticoagulacion:
Menor 48 hrs
Moderado 3 o 4 días
Severo 6 a 7 días

[World Stroke Academy @WorldStrokeEd]

#MondayTip
🧠#WSC2025 stroke pathway
Every step matters:
🚑EVT workflow optimization
💉TNK advancing thrombolysis
🧵MMA embo cutting cSDH recurrence
🤖AI for aneurysm detection
⚡BP control & AF strategies for prevention
Stroke care=team sport & science keeps moving us forward💪

[Practical Neurology @PracticalNeuro]

Adding an #antiplatelet agent to #anticoagulant therapy increased risk of bleeding while offering minimal clinical benefit for people with #ischemic #stroke, #TIA, #NVAF, & #ASCVD. Data published in @JAMANeuro.
https://t.co/1wHhquMS6e
@EVToday @American_Stroke @AANmember

[Oren Gottfried, MD @OGdukeneurosurg]

Eye muscles

[Andreas Charidimou MD, PhD @a_charidimou]

🩸🧠Cerebral Amyloid Angiopathy: Pillars for management
#WSC2025

🔖 Read our full Guidelines on behalf of the @iCAAassociation & @WorldStrokeOrg via @IntJStroke

🔗https://t.co/SiLmWOCFNt

#WSC2025 #NeuroTwitter #stroke #Neurology #neuropath #stroke #dementia #Alzheimers #biomarker #brain #MedStudentTwitter #AmyloidAngiopathy #CAA #cSVD

[Andrea Zini @ZiniAndrea]

Our last paper about #BNP & #TTE parameters as predictor new #AF after #stroke
👫 2,411 IS pts
🩸BNP ⩾150 pg/ml + 🫀LA enlargement have a strong association (aOR 4.74, p< 0.001) for predicting new AF
@AUSLBologna
@escardio
@ESOstroke
@SageJournals
https://t.co/voTcTOeuZ4

[International Journal of Stroke @IntJStroke]

Just Accepted!
🧠📈Incidentally detected asymptomatic ICAS predicts substantial risk of symptomatic transition and subsequent adverse outcomes

Read more here!👇
https://t.co/28JWG5w7GQ @liuyy0152

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE: ETERNAL-LVO trial showed that among LVO patients within 24h + perfusion mismatch, tenecteplase 0.25mg/kg did not improve functional outcomes vs standard care. There was a signal of benefit in transfer subgroup. #AHAJournals https://t.co/z5gcyEga5Q